Linaclotide vs Insulin Degludec
Head-to-head comparison of Linaclotide (Linaclotide) and Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Linaclotide | Insulin Degludec |
|---|---|---|
| Category | Gastrointestinal | Diabetes & Metabolic |
| Full Name | Linaclotide | Insulin degludec (desB30, acylated ultra-long-acting insulin analog) |
| Molecular Weight | 1526.8 Da | 6103.9 Da |
| Half-Life | Active locally; negligible systemic half-life | More than 25 hours |
| Amino Acids | 14 | 50 |
| Typical Dose | 72-290 mcg once daily | 0.1-0.2 U/kg once daily |
| Route | Oral | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 1200 | 7000 |
| Research Status | Clinical | Approved |
Linaclotide Benefits
- ✓improves-bowel-movements
- ✓reduces-abdominal-pain
- ✓increases-intestinal-secretion
- ✓supports-transit
Insulin Degludec Benefits
- ✓Ultra-long basal coverage
- ✓Lower day-to-day variability
- ✓Reduced nocturnal hypoglycemia
- ✓Flexible dosing time
Linaclotide Dosing
72 mcg PO daily|145 mcg PO daily|290 mcg PO daily
Insulin Degludec Dosing
Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults
Linaclotide Side Effects
- ⚠diarrhea
- ⚠abdominal-pain
- ⚠bloating
Insulin Degludec Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Research Overview
Linaclotide
Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.
Insulin Degludec
Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.